The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Latest News Releases


Latest Press Releases from ASCO

Category :

Year :

 
 

ASCO RELEASES STUDIES FROM UPCOMING ANNUAL MEETING

May 16, 2012

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today highlighted five studies in a press briefing from among more than 4,500 abstracts publicly posted online at abstract.asco.org in advance of ASCO’s 47th Annual Meeting.


Cancer.Net Mobile App for Android Just Released

May 10, 2012

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO), the world’s leading professional organization representing cancer physicians, today released Cancer.Net Mobile for Android devices. Cancer.Net Mobile is a free app designed by oncologists to help people with cancer and their caregivers plan and manage cancer treatment and care. The app is the mobile companion to ASCO’s award-winning patient information website Cancer.Net, and it includes comprehensive, doctor-approved information on more than 120 cancer types, along with a package of interactive tools to help patients get the most out of doctor’s visits.


Conquer Cancer Foundation of ASCO to Award More Than $5 Million to Promising Oncology Researchers

May 8, 2012

ALEXANDRIA, Va. – The use of genomic sequencing, understanding the role of epigenetics in tumor progression in non-small cell lung cancer, and identifying novel targeted therapy combinations are among the topics of research being presented by grant and award recipients at this year’s premier oncology meeting in Chicago. The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) will present more than $5 million in grants and awards to more than 200 promising oncology researchers at ASCO’s 48th Annual Meeting, taking place June 1-5, 2012.


New ASCO Guide for Patients Helps Obese Cancer Patients Understand Optimal Weight-Based Chemotherapy Dosing

May 1, 2012

ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) has released recommendations to help obese people living with cancer understand and discuss with their doctors the appropriate dosing of chemotherapy drugs for their body weight. “What to Know: ASCO's Guideline on Chemotherapy Doses for Obese Patients With Cancer” accompanies ASCO’s recent clinical guideline on chemotherapy dosing for obese patients and can be found on ASCO’s award-winning patient information website, Cancer.Net.


Statement from American Society of Clinical Oncology (ASCO) President Michael P. Link, MD, on the Senate Health, Education, Labor and Pension Committee’s Passage of the Food and Drug Administration Safety and Innovation Act

April 25, 2012

ASCO commends the Senate Health, Education, Labor and Pensions Committee for taking steps to address a crisis in cancer care through its reauthorization of prescription drug user fee legislation. Drug shortages are continuing to strike hospitals and oncology practices and threaten patient care throughout the country. In cancer care alone, 19 different therapies remain in short supply.


Oncology State Societies and Practices Recognized for Important Work in Clinical Trials and Promising New Programs that Improve Patient Care

April 24, 2012

ALEXANDRIA, Va. – The Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) is recognizing six oncology practices from around the country for their work in improving access to clinical trials for patients in their communities. In addition, three ASCO State Affiliate societies are being honored for new projects that enhance cancer care in their state and region.


ASCO Continues to Support Oncologists in EHR Adoption at 2012 Annual Meeting; Eight Companies Meet Criteria to Participate in EHR Lab

April 23, 2012

ALEXANDRIA, Va. – As part of its ongoing effort to support oncology practices in adopting Electronic Health Records (EHR) to improve their quality of care, the American Society of Clinical Oncology (ASCO) will hold its sixth annual EHR Vendor Lab, from June 2-4 at the 2012 ASCO Annual Meeting in Chicago, IL. This resource gives attendees the opportunity to test drive different systems that meet ASCO-defined criteria and experience the latest health information technology.


The American Society of Clinical Oncology and the Lance Armstrong Foundation Launch “Moving Forward: Perspectives from Survivors and Doctors,” a Patient Education Video Series for Young Adults with Cancer

April 9, 2012

Alexandria, Va. – The American Society of Clinical Oncology (ASCO) and the Lance Armstrong Foundation today announced the launch of a new video series for young adults with cancer that is featured on ASCO’s patient information website www.cancer.net and on the Foundation’s YouTube site. The series, “Moving Forward: Perspectives from Survivors and Doctors,” addresses critical issues that young adults with cancer may face and helps them better understand and cope with challenges related to their diagnosis.


ASCO Publishes "Top Five" List of Opportunities to Improve Quality and Value in Cancer Care

April 4, 2012

ALEXANDRIA, Va. - The American Society of Clinical Oncology (ASCO) today published a detailed review of the "Top Five" opportunities to improve the quality and value of cancer care by curbing use of common tests and treatments that are not supported by clinical evidence. Published in the Journal of Clinical Oncology, the new article coincides with the announcement of several Top Five lists as part of the Choosing Wisely® campaign. ASCO is one of nine specialty societies participating in the campaign, which is sponsored by the American Board of Internal Medicine (ABIM) Foundation.


ASCO Guideline Recommends the Use of Actual Body Weight to Calculate Appropriate Dose of Chemotherapy Drugs for Obese Patients

April 2, 2012

ALEXANDRIA, Va. – Today the American Society of Clinical Oncology (ASCO) issued a new clinical practice guideline on the appropriate dosing of chemotherapy drugs for obese adult patients with cancer. The guideline recommends that physicians routinely use an obese patient’s actual body weight, rather than an ideal body weight or other estimate, to calculate the appropriate dose of nearly all chemotherapy drugs. The guideline was released on April 2, 2012.


<<Previous | Page 1 of 63 |  Next>>


 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005–2012 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form